Multi-organ Transit Time Acquisition Using Contrast Ultrasound
NCT ID: NCT05135169
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2022-03-03
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety of the PET-511BTM Transesophageal Transducer
NCT00997568
Clinical Evaluation of the Next Generation Venue Ultrasound System, Components, and Accessories - Canada
NCT03653572
Implementing Myocardial Computed Tomographic Perfusion in a Community Hospital Setting
NCT02756234
Pharmacokinetics, Safety, and Lung Deposition of 99mTc-DTPA Delivered Via the EDDIS System in Healthy Volunteers
NCT07053696
Safety of the PET-512MC Transesophageal Transducer
NCT01186380
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Contrast administration
Definity Suspension for Injection
Administration of Definity
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Definity Suspension for Injection
Administration of Definity
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* able to give informed consent
Exclusion Criteria
2. Pregnancy/Nursing - as assessed/disclosed by the participant
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ken Monahan
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VUMC
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB 212087
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.